Rice Hall James & Associates’s Opus Genetics, Inc. Common Stock IRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-223,589
| Closed | -$342K | – | 269 |
|
|
2024
Q2 | $342K | Sell |
223,589
-68,396
| -23% | -$105K | 0.02% | 247 |
|
|
2024
Q1 | $587K | Sell |
291,985
-279,792
| -49% | -$562K | 0.03% | 226 |
|
|
2023
Q4 | $1.72M | Sell |
571,777
-256,851
| -31% | -$773K | 0.1% | 183 |
|
|
2023
Q3 | $2.78M | Sell |
828,628
-20,658
| -2% | -$69.2K | 0.18% | 132 |
|
|
2023
Q2 | $3.69M | Buy |
849,286
+40,169
| +5% | +$174K | 0.21% | 113 |
|
|
2023
Q1 | $3.03M | Buy |
809,117
+3,050
| +0.4% | +$11.4K | 0.17% | 141 |
|
|
2022
Q4 | $2.85M | Buy |
806,067
+265,719
| +49% | +$938K | 0.16% | 144 |
|
|
2022
Q3 | $1.09M | Buy |
540,348
+212,854
| +65% | +$428K | 0.06% | 230 |
|
|
2022
Q2 | $629K | Buy |
327,494
+182,468
| +126% | +$350K | 0.03% | 240 |
|
|
2022
Q1 | $470K | Buy |
145,026
+12,593
| +10% | +$40.8K | 0.02% | 254 |
|
|
2021
Q4 | $494K | Buy |
+132,433
| New | +$494K | 0.02% | 262 |
|